|
2004 Journal Article Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive ratDavis, B. J., Forbes, J. M., Thomas, M. C., Jerums, G., Burns, W. C., Kawachi, H., Allen, T. J. and Cooper, M. E. (2004). Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia, 47 (1), 89-97. doi: 10.1007/s00125-003-1256-8 |
|
2003 Journal Article Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2Osicka, Tanya M., Russo, Leileata M., Qiu, Mei-Lan, Brammar, Gail C., Thallas, Vicki, Forbes, Josephine M., Comper, Wayne D. and Jerums, George (2003). Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2. Journal of Hypertension, 21 (12), 2399-2407. doi: 10.1097/00004872-200312000-00029 |
|
2003 Journal Article Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptorsRizkalla, Bizhoy, Forbes, Josephine M., Cooper, Mark E. and Cao, Zemin (2003). Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. Journal of the American Society of Nephrology, 14 (12), 3061-3071. doi: 10.1097/01.ASN.0000099374.58607.C9 |
|
2003 Journal Article Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular diseaseJerums, George, Panagiotopoulos, Sianna, Forbes, Josephine, Osicka, Tanya and Cooper, Mark (2003). Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Archives of Biochemistry And Biophysics, 419 (1), 55-62. doi: 10.1016/j.abb.2003.08.017 |
|
2003 Conference Publication Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.Boner, G, Thallas, V, Cooper, ME, Rizkalla, B, Qui, ML and Forbes, JM (2003). Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.. 36th Annual Meeting of the American-Society-of-Nephrology, San Diego California, Nov 12-17, 2003. LIPPINCOTT WILLIAMS & WILKINS. |
|
2003 Conference Publication Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711Allen, TJ, Forbes, JM, Yee, LT, Thallas, V, Thomas, MC, Candido, R, Jandeleit-Dahm, KA and Cooper, ME (2003). Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711. 76th Annual Scientific Session of the American-Heart-Association, Orlando Florida, Nov 07-12, 2003. LIPPINCOTT WILLIAMS & WILKINS. |
|
2003 Journal Article Role of advanced glycation end products in diabetic nephropathyForbes, Josephine M., Cooper, Mark E., Oldfield, Matthew D. and Thomas, Merlin C. (2003). Role of advanced glycation end products in diabetic nephropathy. Journal of the American Society of Nephrology, 14 (suppl 3), S254-S258. doi: 10.1097/01.ASN.0000077413.41276.17 |
|
2003 Journal Article Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic ratsOsicka, Tanya M., Forbes, Josephine M., Thallas, Vicki, Brammar, Gail C., Jerums, George and Comper, Wayne D. (2003). Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. Nephrology, 8 (4), 205-211. doi: 10.1046/j.1440-1797.2003.00159.x |
|
2003 Journal Article Reduced tubular cation transport in diabetes: prevented by ACE inhibitionThomas, Merlin C., Tikellis, Chris, Burns, Wendy C., Thallas, Vicki, Forbes, Josephine M., Cao, Zemin, Osicka, Tanya M., Russo, Leileata M., Jerums, George, Ghabrial, Hany, Cooper, Mark E. and Kantharidis, Phillip (2003). Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney International, 63 (6), 2152-2161. doi: 10.1046/j.1523-1755.2003.00006.x |
|
2003 Journal Article A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesCandido, Riccardo, Forbes, Josephine M., Thomas, Merlin C., Thallas, Vicki, Dean, Rachael G., Burns, Wendy C., Tikellis, Christos, Ritchie, Rebecca H., Twigg, Stephen M., Cooper, Mark E. and Burrell, Louise M. (2003). A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circulation Research, 92 (7), 785-792. doi: 10.1161/01.RES.0000065620.39919.20 |
|
2003 Journal Article Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathyTikellis, Christos, Johnston, Colin I., Forbes, Josephine M., Burns, Wendy C., Burrell, Louise M., Risvanis, John and Cooper, Mark E. (2003). Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy. Hypertension, 41 (3), 392-397. doi: 10.1161/01.HYP.0000060689.38912.CB |
|
2003 Journal Article Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organizationClavant, Steven P., Forbes, Josephine M., Thallas, Vicki, Osicka, Tanya M., Jerums, George and Comper, Wayne D. (2003). Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization. Nephron, 93 (2), 51-60. doi: 10.1159/000068528 |
|
2003 Journal Article The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetesForbes, Josephine M, Thallas, Vicki, Thomas, Merlin C, Founds, Hank W, Burns, Wendy C, Jerums, George and Cooper, Mark E (2003). The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 17 (12), 1762-1764. |
|
2002 Journal Article Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. A., Jerums, G. and Osicka, T. M. (2002). Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282)). Diabetes, 51 (12) |
|
2002 Journal Article Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidineTwigg, Stephen M., Cao, Zemin, McLennan, Sue V., Burns, Wendy C., Brammar, Gail, Forbes, Josephine M. and Cooper, Mark E. (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology, 143 (12), 4907-4915. doi: 10.1210/en.2002-220619 |
|
2002 Journal Article Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyForbes, Josephine M., Cooper, Mark E., Thallas, Vicki, Burns, Wendy C., Thomas, Merlin C., Brammar, Gail C., Lee, Fiona, Grant, Sharon L., Burrell, Louise M., Jerums, George and Osicka, Tanya M. (2002). Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes, 51 (11), 3274-3282. doi: 10.2337/diabetes.51.11.3274 |
|
2002 Conference Publication Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.Forbes, JM, Thallas, V, Jerums, G, Thomas, MC and Cooper, ME (2002). Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.Rizkalla, BM, Cao, ZM, Forbes, JM and Cooper, ME (2002). Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.. LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.Cooper, ME, Cao, Z, Candido, R, Forbes, JM, Osicka, TM, Twigg, S and Bonnet, F (2002). Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.. 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Budapest Hungary, Sep 01-05, 2002. SPRINGER-VERLAG. |
|
2002 Conference Publication Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?Davis, BJ, Forbes, JM, Jerums, G, Cooper, ME and Allen, TJ (2002). Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?. 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting, Prague Czech Republic, Jun 23-27, 2002. LIPPINCOTT WILLIAMS & WILKINS. |
